Found: 6
Select item for more details and to access through your institution.
Challenges and approaches for the development of safer immunomodulatory biologics.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 4, p. 306, doi. 10.1038/nrd3974
- By:
- Publication type:
- Article
Characterization of a novel potency endpoint for the evaluation of immune checkpoint blockade in humanized mice.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1107848
- By:
- Publication type:
- Article
The future trajectory of adverse outcome pathways: a commentary.
- Published in:
- Archives of Toxicology, 2018, v. 92, n. 4, p. 1657, doi. 10.1007/s00204-018-2183-2
- By:
- Publication type:
- Article
Use of human splenocytes in an innovative humanised mouse model for prediction of immunotherapy‐induced cytokine release syndrome.
- Published in:
- Clinical & Translational Immunology, 2020, v. 9, n. 11, p. 1, doi. 10.1002/cti2.1202
- By:
- Publication type:
- Article
The role of ADP-ribosylation and G[sub M1]-binding activity in the mucosal immunogenicity and....
- Published in:
- Immunology & Cell Biology, 1998, v. 76, n. 3, p. 270, doi. 10.1046/j.1440-1711.1998.00745.x
- By:
- Publication type:
- Article
Mutational analysis of the role of ADP-ribosylation activity and G.
- Published in:
- European Journal of Immunology, 1998, v. 28, n. 4, p. 1243, doi. 10.1002/(SICI)1521-4141(199804)28:04<1243::AID-IMMU1243>3.0.CO;2-E
- By:
- Publication type:
- Article